These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 10139488)

  • 1. Special issue: Health care technology and its assessment in eight countries: Australia, Canada, France, Germany, Netherlands, Sweden, United Kingdom, United States.
    Health Policy; 1994; 30(1-3):1-421. PubMed ID: 10139488
    [No Abstract]   [Full Text] [Related]  

  • 2. Health care technology as a policy issue.
    Banta HD
    Health Policy; 1994; 30(1-3):1-21. PubMed ID: 10139487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lessons from the eight countries.
    Battista RN; Banta HD; Jonnson E; Hodge M; Gelband H
    Health Policy; 1994; 30(1-3):397-421. PubMed ID: 10139496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The management of health care technology in nine countries. Summary and analysis.
    Banta HD; Russell LB
    Springer Ser Health Care Soc; 1982; 7():193-237. PubMed ID: 10259694
    [No Abstract]   [Full Text] [Related]  

  • 5. [Conception and conversion of medical technology assessment--an international comparison].
    Berndt K; Hinzpeter B; Kurscheid T; Lauterbach KW
    Z Arztl Fortbild Qualitatssich; 1998 May; 92(4):255-62. PubMed ID: 9675828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International diffusion of new health technologies: a ten-country analysis of six health technologies.
    Packer C; Simpson S; Stevens A;
    Int J Technol Assess Health Care; 2006; 22(4):419-28. PubMed ID: 16984674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technology for the continuous improvement of the quality of health care.
    Racoveanu NT; Johansen KS
    World Health Forum; 1995; 16(2):138-44. PubMed ID: 7794449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rethinking well-child care in the United States: an international comparison.
    Kuo AA; Inkelas M; Lotstein DS; Samson KM; Schor EL; Halfon N
    Pediatrics; 2006 Oct; 118(4):1692-702. PubMed ID: 17015563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The development of health care technology assessment. An international perspective.
    Battista RN; Hodge MJ
    Int J Technol Assess Health Care; 1995; 11(2):287-300. PubMed ID: 7790172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immigration policies: a comparative overview.
    Widgren J
    People Place; 1994; 2(4):1-8. PubMed ID: 12290263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New drug approval times and 'therapeutic potential' in Canada, Australia, Sweden and the United States during the period 1992 to 1998.
    Rawson NS; Kaitin KI
    Can J Clin Pharmacol; 2000; 7(2):97-101. PubMed ID: 10958705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health care technology assessment: linking science and policy-making.
    Battista RN
    CMAJ; 1992 Feb; 146(4):461-2. PubMed ID: 1737310
    [No Abstract]   [Full Text] [Related]  

  • 13. Health care expenditures in nine industrialized countries, 1960-76.
    Simanis JG; Coleman JR
    Soc Secur Bull; 1980 Jan; 43(1):3-8. PubMed ID: 6769168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In chronic condition: experiences of patients with complex health care needs, in eight countries, 2008.
    Schoen C; Osborn R; How SK; Doty MM; Peugh J
    Health Aff (Millwood); 2009; 28(1):w1-16. PubMed ID: 19008253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluations of health interventions in social insurance-based countries: Germany, the Netherlands, and Austria.
    Wild C; Gibis B
    Health Policy; 2003 Feb; 63(2):187-96. PubMed ID: 12543531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward rational technology in medicine: considerations for health policy.
    Banta HD; Behney CJ; Willems JS
    Springer Ser Health Care Soc; 1981; 5():v-xiv, 1-242. PubMed ID: 10309422
    [No Abstract]   [Full Text] [Related]  

  • 17. Determinants of hospital utilization: the situation in Israel and selected countries.
    Benbassat J; Haklai Z; Glick S; Friedman N
    Isr Med Assoc J; 2000 Nov; 2(11):833-7. PubMed ID: 11344753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evolving paradigm of health technology assessment: reflections for the millennium.
    Battista RN; Hodge MJ
    CMAJ; 1999 May; 160(10):1464-7. PubMed ID: 10352637
    [No Abstract]   [Full Text] [Related]  

  • 19. Health technology assessment of cancer drugs in Canada, the United Kingdom and Australia: should the United States take notice?
    Dranitsaris G; Papadopoulos G
    Appl Health Econ Health Policy; 2015 Jun; 13(3):291-302. PubMed ID: 25274258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dutch committee assesses the future of health technology.
    Banta HD
    Dimens Health Serv; 1986 Oct; 63(7):17-20. PubMed ID: 3781116
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.